MEDOVEX CORP's ticker is MDVX and the CUSIP is 58504H101. A total of 6 filers reported holding MEDOVEX CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $154,000 | +266.7% | 150,000 | +200.0% | 0.04% | +80.0% |
| Q2 2017 | $42,000 | -44.7% | 50,000 | 0.0% | 0.02% | -46.8% |
| Q1 2017 | $76,000 | +15.2% | 50,000 | 0.0% | 0.05% | +6.8% |
| Q4 2016 | $66,000 | -10.8% | 50,000 | 0.0% | 0.04% | -12.0% |
| Q3 2016 | $74,000 | +12.1% | 50,000 | 0.0% | 0.05% | +11.1% |
| Q2 2016 | $66,000 | +26.9% | 50,000 | 0.0% | 0.04% | +25.0% |
| Q1 2016 | $52,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MERIDIAN INVESTMENT COUNSEL INC. | 50,000 | $42,000 | 0.02% |
| Bison Wealth, LLC | 10,000 | $8,000 | 0.01% |
| NORTHERN TRUST CORP | 12,539 | $11,000 | 0.00% |
| DEUTSCHE BANK AG\ | 3,140 | $2,000 | 0.00% |
| Fisher Asset Management, LLC | 27,500 | $23,000 | 0.00% |
| BlackRock Inc. | 6,163 | $5,000 | 0.00% |
| Citadel Advisors | 29,298 | $26,000 | 0.00% |
| VANGUARD GROUP INC | 32,705 | $29,000 | 0.00% |
| UBS Group AG | 6,823 | $6,000 | 0.00% |